All trials - page: 92

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT06094205Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)Massachusetts General Hospital
  • Age 18 - 80 yrs
  • Level C1-T1
  • AIS
  • ≥ 12 months
Recruiting2NATechnologyMental health and psychosocial factors
  • Adverse Events (AEs)
1-5 years16 October 202323 October 20232
NCT05730049Neuromodulation as an Anti-inflammatory Treatment in SCILondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
  • Age ≥ 18 yrs
  • Level C1-S5
  • AIS
  • All
  • NOT have implanted device, e.g., pacemaker.
Recruiting30NATechnologyGeneral health
  • Serum Biomarker
24 hours01 January 202415 February 20231
NCT06072001Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any GenesisApurano Pharmaceuticals GmbHParallel Assignment
  • Age ≥ 18 yrs
  • Level C1-S5
  • AIS
  • All
  • NOT have a history of addiction.
  • understand German.
Recruiting558Phase 3DrugPain
  • Brief Pain Inventory (BPI)
  • Depression Anxiety Stress Scale-21 (DASS-21)
  • Neuropathoc Pain Symptom Inventory (NPSI)
  • Pain Numeric Rating Scale (NRS)
52 weeks02 November 202310 October 20231
NCT05982171Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord InjuryCraig Hospital
  • Age ≥ 18 yrs
  • Level C4-T10
  • AIS B, C, D
  • ≤ 12 months
  • must be between 5'0" and 6'4" in height
  • NOT have a cauda equina injury
  • NOT have cardiac or respiratory issues
Recruiting30NATechnologyStanding/walking/mobility
  • 10 Meter Walking Test (10 MWT)
  • 6-Minute Walk Test (6MWT)
  • Neurogenic Bladder Symptom Score
  • Neurogenic Bowel Dysfunction Score (NBD or NBDS)
  • Penn Spasm Frequency Scale (PSFS)
  • Walking Index for Spinal Cord Injury (WISCI) and WISCI II
4 weeks after the last session15 November 202308 August 20231
NCT05920174Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor DisabilityNeuracle Medical Technology(Shanghai) Co.,Ltd.Single Group Assignment
  • Age 18 - 80 yrs
  • Level C1-C8
  • AIS A, B, C, D
  • ≥ 1 years
Recruiting soon9Not ApplicableTechnologyGeneral health
  • Adverse Events (AEs)
12 months01 July 202327 June 20233
NCT05870189Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord InjuryUniversity of Minnesota
  • Age 18 - 75 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • ≥ 3 months
Ended19PHASE2RehabilitationStanding/walking/mobility
  • American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
  • Neuromuscular Recovery Scale
12 weeks01 June 202323 May 20231